Noninfective valvular masses: Review of the literature with emphasis on imaging techniques and management

American Heart Journal

Volumn 131, Issue 6, 1996, Pages 1175-1183

  Joffe, Ian I ^a   Jacobs, Larry E ^a   Owen, Alyson N ^a   Ioli, Alfred ^a   Kotler, Morris N ^a  

^a ALBERT EINSTEIN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; HEPARIN; WARFARIN;

ANTIPHOSPHOLIPID SYNDROME; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; ENDOCARDITIS; FIBROELASTOMA; HEART TUMOR; HUMAN; PRIORITY JOURNAL; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; VALVULAR HEART DISEASE;

EID: 0029997960     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(96)90094-0     Document Type: Article

References (62)

1. Almagro UA, Perry LS, Choi H, Pintar K. Papillary fibroelastoma of the heart. Arch Pathol Lab Med 1982;106:318-21.
2. Doherty NE, Siegel RJ. Cardiovascular manifestations of systemic lupus erythematosus. Am Heart J 1985;110:1257-65.
3. Mills J, Abbot J, Utley J, Ryan C. Role of cardiac catheterization in infective endocarditis. Chest 1977;72:576-82.
4. McAllister HA Jr, Fenoglio JJ Jr. Tumors of the cardiovascular system. In: Atlas of tumor pathology, second series, Fascicle 15. Washington, DC: Armed Forces Institute of Pathology, 1978,20-5.
5. Hurle JM, Garcia-Martinez V, Sanchez-Quintana D. Morphologic characteristics and structure of surface excrescences (Lambl's excrescences) in the normal aortic valve. Am J Cardiol 1986;58:1223-7.
6. Weyman AE. Principles and practice of echocardiography. Philadelphia: Lea and Febiger, 1994:75-97.
7. Shapira N, Fernandez J, McNicholas KW, Serra AJ, Hirschfeld K, Spagna PM, Lemole GM. Hypertrophy of nodules of Arantius and aortic insufficiency: pathophysiology and repair. Ann Thorac Surg 1991; 51:969-72.
8. Libman E, Sacks B. A hitherto undescribed form of valvular and mural endocarditis. Arch Intern Med 1924;33:701-37.
9. Bridgen W, Bywaters EGL, Lessof MH, Ross IP. The heart in systemic lupus erythematosus. Br Heart J 1960;22:1-16.
10. Kong TQ, Kellum RE, Haserick JR. Clinical diagnosis of cardiac involvement in systemic lupus erythematosus: A correlation of clinical and autopsy findings in thirty patients. Circulation 1962;26:7-11.
11. Hejtmancik MR, Wright JC, Quint R, Jennings FL. The cardiovascular manifestations of systemic lupus erythematosus. Am Heart J 1964; 68:119-30.
12. Galve E, Candell-Riera J, Pigrau C, Permanyer-Miralda G, Garcia-Del-Castillo H, Soler-Soler J. Prevalence, morphologic types, and evolution of cardiac valvular disease in systemic lupus erythematosus. N Engl J Med 1988;319:817-23.
13. Gleason CB, Stoddard MF, Wagner SG, Longaker RA, Pierangeli S, Harris EN. A comparison of cardiac valvular involvement in the primary antiphospholipid syndrome versus anticardiolipin-negative systemic lupus erythematous. Am Heart J 1993;125:1123-29.
14. Appelbe AF, Olson D, Mixon R, Craver JM, Martin RP. Libman-Sacks endocarditis mimicking intracardiac tumor. Am J Cardiol 1991; 68:817-8.
15. Futrell N, Millikan C. Frequency, etiology, and prevention of stroke in patients with systemic lupus erythematosus. Stroke 1989;20:583-91.
16. Mitsias P, Levine SR. Large cerebral vessel occlusive disease in systemic lupus erythematosus. Neurology 1994;44:385-93.
17. Futrell N, Schultz LR, Millikan C. Central nervous system disease in patients with systemic lupus erythematosus. Neurology 1992;42:1649-57.
18. Eustace S, Hutchinson M, Bresnihan B. Acute cerebrovascular episodes in systemic lupus erythematosus. Q J Med 1991;293:739-50.
19. Devinsky O, Petito CK, Alonso DR. Clinical and neuropathological findings in systemic lupus erythematosus: the role of vasculitis, heart emboli, and thrombotic thromboeytopenic purpura. Ann Neurol 1988; 23:380-4.
20. Khamashta MA, Cervera R, Asherson RA, Font J, Gil A, Coltart DJ, Vazquez JJ, Pare C, Ingelmo M, Oliver J, Hughes GRV. Association of antibodies against phospholipids with heart valve disease in systemic lupus erythematosus. Lancet 1990;335:1541-4.
21. Asherson RA, Khamashta MA, Ordi-Ros J, Derksen RHWM, Machin SJ, Barquinero J, et al. The "primary" antiphospholipid syndrome: major clinical and serological features. Medicine 1989;68:366-74.
22. Brenner B, Blumenfeld Z, Markiewicz W, Reisner SA. Cardiac involvement in patients with primary antiphospholipid syndrome. J Am Coll Cardiol 1991;18:931-6.
23. Galve E, Ordi J, Barquinero J, Evangelista A, Vilardell M, Soler-Soler J. Valvular heart disease in the primary antiphospholipid syndrome. Ann Intern Med 1992;116:293-8.
24. Murphy JJ, Leach IH. Findings at necropsy in the heart of a patient with anticardiolipin syndrome. Br Heart J 1989;62:61-4.
25. Turiel M, Rossi E, Crema C, Frisinghelli A, Muzzupappa S, Serrago M. Cardiac involvement and anticardiolipin antibodies levels in antiphospholipid syndrome: a transesophageal study. J Am Coll Cardiol 1995; Feb:399A.
26. Hart RG, Miller VT, Coull BM, Bril V. Cerebral infarction associated with lupus anticoagulants - preliminary report. Stroke 1984;15:114-8.
27. Chartash EK, Lans DM, Paget SA, Qamar T, Lockshin MD. Aortic insuffiency and mitral regurgitation in patients with systemic lupus erythematosus and the antiphospholipid syndrome. Am J Med 1989; 86:407-12.
28. Pope JM, Canny CLB, Bell DA. Cerebral ischemic events associated with endocarditis, retinal vascular disease, and lupus anticoagulant. Am J Med 1991;90:299-309.
29. Anderson D, Bell D, Lodge R, Grant E. Recurrent cerebral ischemia and mitral valve vegetation in a patient with antiphospholipid antibodies. J Rheumatol 1987;14:839-41.
30. Ehrie M, Morgan AP, Moore FD, O'Connor NE. Endocarditis with indwelling balloon-tipped pulmonary artery catheter in burn patients. J Trauma 1978;18:664-6.
31. Garcia I, Fainstein V, Rios A, Luna M, Mansell P, Reuben J, Hersh E. Nonbacterial thrombotic endocarditis in a male homosexual with Kaposi's sarcoma. Arch Intern Med 1983;143:1243-4.
32. Lopez JA, Ross RS, Fishbein MC, Siegel RJ. Nonbacterial thrombotic endocarditis: a review. Am Heart J 1987;113:773-84.
33. Sack GH, Levin J, Bell WR. Trousseau's syndrome and other manifestations of chronic disseminated coagulopathy in patients with neoplasms: clinical, pathophysiologic, and therapeutic features. Medicine 1977;56:1-37.
34. Bessis D, Sotto A, Viard J, Berard M, Ciurana A, Boffa M. Trousseau's syndrome with nonbacterial thrombotic endocarditis: pathogenic role of antiphospholipid syndrome. Am J Med 1995;98:511-3.
35. Estevez CM, Corya BC. Serial echocardiographic abnormalities in nonbacterial thrombotic endocarditis of the mitral valve. Chest 1976; 69:801-4.
36. Siegel RJ, Ginzton LE, Flanagan K, Criley JM. Marantic endocarditis. Diagnosis by 2-D echocardiography. Chest 1981;80:118-9.
37. Lopez JA, Fishbein MC, Siegel RJ. Echocardiographic features of non-bacterial thrombotic endocarditis. Am J Cardiol 1987;59:478-80.
38. Biller J, Johnson MR, Adams HP Jr, Kerber RE, Toffol GJ, Butler MJ. Echocardiographic evaluation of young adults with nonhemorrhagic cerebral infarction. Stroke 1986;17:608-12.
39. Shuaib A. Stroke from other etiologies masquerading as migraine-stroke. Stroke 1991;22:1068-74.
40. Shively BK, Gurule FT, Roldan CA, Leggett JH, Schiller NB. Diagnostic value of transesophageal compared with transthoracic echocardiography in infective endocarditis. J Am Coll Cardiol 1991;18:391-7.
41. Blanchard DG, Ross RS, Dittrich HC. Nonbacterial thrombotic endocarditis. Assessment by transesophageal echocardiography. Chest 1992;102:954-6.
42. Colucci WS, Braunwald E. Primary tumors of the heart. In: Braunwald E, editor. Heart disease: a textbook of cardiovascular medicine. Philadelphia: W.B. Saunders Company, 1992:1451-64.
43. de Virgilio C, Dubrow TJ, Robertson JM, Siegel S, Ginzton L, Nussmeier M, Nelson RJ. Detection of multiple cardiac papillary fibroelastomas using transesophageal echocardiography. Ann Thorac Surg 1989;48:119-21.
44. Frumin H, O'Donnel L, Kerin NZ, Levine F, Nathan LE, Klein SP. Two-dimensional echocardiographic detection and diagnostic features of tricuspid papillary fibroelastoma. J Am Coll Cardiol 1983;2:1016-8.
45. McFadden PM, Lacy JR. Intracardiac papillary fibroelastoma: an occult cause of embolic neurologic deficit. Ann Thorac Surg 1987; 43:667-9.
46. Topol EJ, Biern RO, Reitz BA. Cardiac papillary fibroelastoma and stroke. Am J Med 1986;80:129-32.
47. Wolfe JT III, Finck SJ, Safford RE, Persellin ST. Tricuspid valve papillary fibroelastoma: echocardiographic characterization. Ann Thorac Surg 1991;51:116-8.
48. Klarich KW, Sarano ME, Gura GM, Tajik AJ, Seward JB. Papillary fibroelastoma: a review of echocardiographic criteria for diagnosis with pathologic correlation. J Am Coll Cardiol 1995;Feb;167A.
49. Levinsky L, SrinivasanV, Gingell RL, Fisher JE, Pieroni DR, Choh JH, Subramanian S. Papillary fibroelastoma of aortic and mitral valves following myomectomy for idiopathic subaortic stenosis. Thorac Cardiovasc Surg 1981;29:187-91.
50. Lee KS, Topol EJ, Stewart WJ. Atypical presentation of papillary fibroelastoma mimicking multiple vegetations in suspected subacute bacterial endocarditis. Am Heart J 1993;125:1443-5.
51. Tunkel AR, Kaye D. Endocarditis with negative blood cultures. N Engl J Med 1992;326:1215-7.
52. Callander N, Rapaport SI. Trousseau's syndrome. West J Med 1993; 158:364-71.
53. Kazakis DJ, Lewis JF, Conti CR. Transesophageal echocardiography in the evaluation of cardiac myxoma: a case of familial myxoma. Clin Cardiol 1995;18:283-5.
54. Lockshin MD. Answers to the antiphospholipid syndrome? N Engl J Med 1995;332:1025-7.
55. Khamashta MA, Cuadrado MJ, Mujic F, Taub NA, Hunt BJ, Hughes GRV. The management of thrombosis in the antiphospholipid-antibody syndrome. N Engl J Med 1995;332:993-7.
56. Skyrme-Jones RAP, Wardrop CAJ, Wiles CM, Fraser AG. Transesophageal echocardiographic demonstration of resolution of mitral vegetations after warfarin in a patient with the primary antiphospholipid syndrome. J Am Soc Echocardiogr 1995;8:251-6. 1995;8:251-6.
57. Skyrme-Jones RAP, Wardrop CAJ, Wiles CM, Fraser AG. Transesophageal echocardiographic demonstration of resolution of mitral vegetations after warfarin in a patient with the primary antiphospholipid syndrome. J Am Soc Echocardiogr 1995;8:251-6. 1995;8:251-6.
58. Hughes GRV. The antiphospholipid syndrome: ten years on. Lancet 1993;342:341-4.
59. Edwards FH, Hale D, Cohen A, Thompson L, Pezzella T, Virmani R. Primary cardiac valve tumors. Ann Thorac Surg 1991;52:1127-31.
60. Shahian DM, Labib SB, Chang G. Cardiac papillary fibroelastoma. Ann Thorac Surg 1995;59:538-41.
61. Mugge A, Daniel WG, Frank G, Lichtlen PR. Echocardiography in infective endocarditis: reassessment of prognostic implications of vegetation size determined by the transthoracic and the transesophageal approach. J Am Coll Cardiol 1989;14:631-8.
62. Bell WR, Starksen NF, Tong S, Porterfield JK. Trousseau's syndrome. Devastating coagulopathy in the absence of heparin. Am J Med 1985; 79:423-30.